Results after multivisceral resections of locally advanced colorectal cancers: An analysis on clinical and pathological t4 tumors
Özet
Background: Locally advanced colorectal cancers are best treated with multivisceral resections. The aim of this study is to evaluate early and late results after multivisceral resections.Methods: All patients operated for primary colorectal cancer between 2001 and 2010 were -reviewed. These were compared within the patients underwent single organ and multivisceral resections: demographics, tumor and procedure related parameters, perioperative results, early oncological outcomes and 5-year survival.Results: A total of 354 patients (59.6 ± 13.8 years old, 210 [59.3%] males) were abstracted. Ninety (25.4%) patients underwent multivisceral resections for clinical T4 tumors and en-bloc R0 resection was achieved in 82 (91.1%). Only 31 (34.4% and 8.8% of clinical T4 and all cancers, respectively) cases had actual adjacent organ invasions (pT4). Males (20%) had lower risk for locally advanced tumors than females (33.3%) (p < 0.05). PT4 cancers were more common, if the clinical T4 tumor is located in the colon (48.8% vs 21.3%; p < 0.01). Laparoscopy was seldom initiated and the risk of conversion was higher in clinical T4 tumors (p < 0.05). The rates of sphincter-saving procedures were not different. Operation time, bleeding and transfusion requirements increased when multivisceral resections were necessitated (p < 0.05), but hospital stay, complications and 30-day mortality rates were similar. The 5-year survival rates were identical (p > 0.05).Conclusions: Clinical T4 tumors are not rare and more common in women. An actual invasion (pT4) may be observed in one third of all clinical T4 tumors, and more frequent in colon cancers. An en-bloc, R0, multivisceral resection may be achieved in most cases. Multivisceral resections do not alter the rates of sphincter-saving procedures, morbidity and 30-day mortality; do not worsen survival but increase operation time, intraoperative bleeding and perioperative transfusion requirements.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Gezen, Cem | |
| dc.contributor.author | Kement, Metin | |
| dc.contributor.author | Altuntas, Yunus E. | |
| dc.contributor.author | Okkabaz, Nuri | |
| dc.contributor.author | Seker, Mesut | |
| dc.contributor.author | Vural, Selahattin | |
| dc.contributor.author | Gumus, Mahmut | |
| dc.contributor.author | Oncel, Mustafa | |
| dc.date.accessioned | 2026-10-22T10:23:55.507752878Z | |
| dc.date.available | 2026-10-22T10:23:55.507752878Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | Background: Locally advanced colorectal cancers are best treated with multivisceral resections. The aim of this study is to evaluate early and late results after multivisceral resections.Methods: All patients operated for primary colorectal cancer between 2001 and 2010 were -reviewed. These were compared within the patients underwent single organ and multivisceral resections: demographics, tumor and procedure related parameters, perioperative results, early oncological outcomes and 5-year survival.Results: A total of 354 patients (59.6 ± 13.8 years old, 210 [59.3%] males) were abstracted. Ninety (25.4%) patients underwent multivisceral resections for clinical T4 tumors and en-bloc R0 resection was achieved in 82 (91.1%). Only 31 (34.4% and 8.8% of clinical T4 and all cancers, respectively) cases had actual adjacent organ invasions (pT4). Males (20%) had lower risk for locally advanced tumors than females (33.3%) (p < 0.05). PT4 cancers were more common, if the clinical T4 tumor is located in the colon (48.8% vs 21.3%; p < 0.01). Laparoscopy was seldom initiated and the risk of conversion was higher in clinical T4 tumors (p < 0.05). The rates of sphincter-saving procedures were not different. Operation time, bleeding and transfusion requirements increased when multivisceral resections were necessitated (p < 0.05), but hospital stay, complications and 30-day mortality rates were similar. The 5-year survival rates were identical (p > 0.05).Conclusions: Clinical T4 tumors are not rare and more common in women. An actual invasion (pT4) may be observed in one third of all clinical T4 tumors, and more frequent in colon cancers. An en-bloc, R0, multivisceral resection may be achieved in most cases. Multivisceral resections do not alter the rates of sphincter-saving procedures, morbidity and 30-day mortality; do not worsen survival but increase operation time, intraoperative bleeding and perioperative transfusion requirements. | |
| dc.identifier.articlenumber | 39 | |
| dc.identifier.doi | 10.1186/1477-7819-10-39 | |
| dc.identifier.issn | 1477-7819 | |
| dc.identifier.pmid | 22336589 | |
| dc.identifier.scopus | 2-s2.0-84857010253 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/15367 | |
| dc.identifier.volume | 10 | |
| dc.identifier.wos | WOS:000301671000003 | |
| dc.language.iso | en | |
| dc.publisher | BIOMED CENTRAL LTD | |
| dc.relation.ispartof | World Journal of Surgical Oncology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Colorectal cancer | |
| dc.subject | Locally advanced colorectal cancer | |
| dc.subject | Morbidity and mortality | |
| dc.subject | Multivisceral resection | |
| dc.subject | PT4 tumor | |
| dc.subject | Survival | |
| dc.subject.classification | Oncology | |
| dc.subject.classification | Surgery | |
| dc.subject.other | Adenocarcinoma | |
| dc.subject.other | Colorectal Neoplasms | |
| dc.subject.other | Female | |
| dc.subject.other | Follow-Up Studies | |
| dc.subject.other | Humans | |
| dc.subject.other | Lymphatic Metastasis | |
| dc.subject.other | Male | |
| dc.subject.other | Middle Aged | |
| dc.subject.other | Neoplasm Recurrence, Local | |
| dc.subject.other | Neoplasm Staging | |
| dc.subject.other | Postoperative Complications | |
| dc.subject.other | Prognosis | |
| dc.subject.other | Prospective Studies | |
| dc.subject.other | Survival Rate | |
| dc.subject.other | Viscera | |
| dc.subject.other | adult | |
| dc.subject.other | advanced cancer | |
| dc.subject.other | article | |
| dc.subject.other | bladder | |
| dc.subject.other | blood transfusion | |
| dc.subject.other | cancer invasion | |
| dc.subject.other | cancer mortality | |
| dc.subject.other | cancer staging | |
| dc.subject.other | cancer surgery | |
| dc.subject.other | cancer survival | |
| dc.subject.other | chemoradiotherapy | |
| dc.subject.other | colorectal cancer | |
| dc.subject.other | heart failure | |
| dc.subject.other | hemicolectomy | |
| dc.subject.other | histopathology | |
| dc.subject.other | hospitalization | |
| dc.subject.other | human | |
| dc.subject.other | lung embolism | |
| dc.subject.other | lung infection | |
| dc.subject.other | lymph node metastasis | |
| dc.subject.other | major clinical study | |
| dc.subject.other | morbidity | |
| dc.subject.other | operation duration | |
| dc.subject.other | ovary | |
| dc.subject.other | perioperative period | |
| dc.subject.other | pneumonia | |
| dc.subject.other | proctocolectomy | |
| dc.subject.other | sepsis | |
| dc.subject.other | small intestine | |
| dc.subject.other | sphincter | |
| dc.subject.other | treatment outcome | |
| dc.subject.other | tumor localization | |
| dc.subject.other | ureter | |
| dc.subject.other | colorectal tumor | |
| dc.subject.other | follow up | |
| dc.subject.other | metastasis | |
| dc.subject.other | mortality | |
| dc.subject.other | pathology | |
| dc.subject.other | postoperative complication | |
| dc.subject.other | prospective study | |
| dc.subject.other | tumor recurrence | |
| dc.title | Results after multivisceral resections of locally advanced colorectal cancers: An analysis on clinical and pathological t4 tumors | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.openalex | 85 | |
| rdl.citation.scopus | 74 | |
| rdl.citation.wos | 64 | |
| rdl.oa.status | gold | |
| rdl.oa.url | https://wjso.biomedcentral.com/counter/pdf/10.1186/1477-7819-10-39 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

